Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Mark won the ITV Tyne Tees Fundraiser of the Year Award and represented the region at the Pride of Britain Awards in London in October.
Here's your Tyne Tees forecast for the rest of the weekend
Money raised for a Down Syndrome charity by the mother of a little girl with the condition has been stolen in a suspected burglary.